Foxx Development (NASDAQ:FOXX) Issues Quarterly Earnings Results

Posted by Tristan Rich on May 21st, 2026

Foxx Development (NASDAQ:FOXX – Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($5.19) EPS for the quarter, FiscalAI reports. The business had revenue of $8.67 million for the quarter.

Foxx Development Stock Performance

Shares of FOXX stock opened at $3.94 on Thursday. The firm’s 50-day moving average is $4.88 and its 200-day moving average is $4.53. The stock has a market cap of $27.62 million, a price-to-earnings ratio of -1.74 and a beta of -0.10. Foxx Development has a 52-week low of $1.71 and a 52-week high of $8.88.

Institutional Investors Weigh In On Foxx Development

A hedge fund recently bought a new stake in Foxx Development stock. Citadel Advisors LLC purchased a new stake in Foxx Development Holdings Inc. (NASDAQ:FOXX – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 12,025 shares of the company’s stock, valued at approximately $57,000. Citadel Advisors LLC owned 0.18% of Foxx Development as of its most recent SEC filing. 60.44% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised shares of Foxx Development from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 13th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

View Our Latest Report on FOXX

About Foxx Development

(Get Free Report)

Foxx Development, Inc (NASDAQ: FOXX) operates as a contract manufacturer specializing in the design, assembly and distribution of medical devices and components. The company’s core business centers on phlebotomy and blood collection products, serving clinical laboratories, hospitals and diagnostic testing facilities. Its product portfolio includes evacuated blood collection tubes, safety-engineered winged blood collection sets, syringes and ancillary devices used in specimen collection and handling.

Founded in North Carolina, Foxx Development maintains a manufacturing and distribution campus in Apex, where it integrates engineering, quality control and regulatory compliance under one roof.